article thumbnail

What does increasing regulatory oversight mean for the pharma supply chain?

The Network Effect

Due to more complex supply chains, policy makers worldwide are enforcing stricter regulations for manufacturing and logistics. Within a decade, the number of FDA warning letters sent to medical device manufacturers has increased threefold, from 61 letters in 2002 to 181 in 2012 (EC A 2012). Pharmaceutical Regulation'

article thumbnail

The 10 Trends Transforming the Pharma Supply Chain

The Network Effect

Today is the first in a series of posts that explores what are in my opinion the ten most significant trends that are transforming the pharmaceutical supply chain. The market for Over-the-Counter (OTC) medicines is now forecast to outgrow the total current pharmaceutical market. Number 2: The Growing Demand for S&OP.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The transforming pharmaceutical supply chain

The Network Effect

I was just with one of the leading global pharmaceutical company yesterday, and once again I was struck by how quickly the pharmaceutical supply chain is changing. The market for Over-the-Counter (OTC) medicines is now forecast to outgrow the total current pharmaceutical market. The rise of OTC and Generics .

article thumbnail

Drug Supply Chain Security Act (DSCSA) Overview: Are You Ready?

QAD

Pharmaceutical manufacturers and their supply, contract packaging and distribution partners are under constant pressure to comply with government requirements while maintaining high standards for patient safety, product quality and innovation. What is the Drug Supply Chain Security Act (DSCSA)? consumers.”.

article thumbnail

Famar integrates pharma specific constraints in supply chain

Supply Chain Movement

Famar, a provider of contract manufacturing and development services to the pharmaceutical and health & beauty industry, has implemented the planning and scheduling functions of OMP Plus in four sites across Europe. In addition, feedback from the factory floor is incorporated into the solution to update the schedule.

article thumbnail

How Counterfeit Pharmaceuticals Hurt Manufacturers

RFgen

Manufacturers use data collection devices to tell real pharmaceutical products from fakes. Counterfeit pharmaceuticals are dangerous to businesses and consumers. With the rise of e-commerce and global supply chains, these drugs are increasingly difficult to track. CNN shared the conclusions of a 2014 U.S.

article thumbnail

How Counterfeit Pharmaceuticals Hurt Manufacturers

RFgen

Manufacturers use data collection devices to tell real pharmaceutical products from fakes. Counterfeit pharmaceuticals are dangerous to businesses and consumers. With the rise of e-commerce and global supply chains, these drugs are increasingly difficult to track. CNN shared the conclusions of a 2014 U.S.